Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Antipsychotic Drugs Market From 2025 to 2029?

There has been substantial growth in the size of the antipsychotic drugs market in the recent past. The market is projected to escalate from $19.5 billion in 2024 to $21.25 billion in 2025, yielding a compound annual growth rate (CAGR) of 9.0%. This historic growth is due to a surge in mental health disorders, development of second-generation antipsychotics, an expanding elderly population, enhancements in healthcare facilities, and significant investment in research and development.

The market for antipsychotic drugs is expected to experience robust growth in the coming years, projecting to reach $30.39 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%. The surge in this projected period can be linked to the rising cases of schizophrenia and bipolar disorder, along with progressive government policies and funding. Increasing preferences for personalized medications, aiming to minimize side effects, and the growth of mental health activism and support groups also contribute. The horizon period will see key trends such as the integration of digital health monitoring tools, breakthrough developments in mechanisms of action, a heightened focus on combined therapies, the usage of pharmacogenomics for custom treatments, and a patient-focused approach towards drug development.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18780&type=smp

What Elements Are Contributing To Growth In The Antipsychotic Drugs Market?

The rise in mental health disorders is predicted to fuel the expansion of the antipsychotic drug market. Mental illnesses can significantly influence an individual’s thought processes, behavior, emotions, and overall mental health. These disorders can result from a variety of factors, including stress, societal expectations, inherited traits, chemical imbalances in the brain, developmental issues within the nervous system, and physical health problems. Antipsychotic medications work by modifying the functions of neurotransmitters, primarily dopamine and serotonin, to alleviate psychotic symptoms, stabilize emotions, and enhance cognitive and emotional performances. For example, a survey by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based public health government agency, revealed that nearly 6% of adults over 18 years old, amounting to 15.4 million people, reported serious mental illness (SMI) in November 2023. Moreover, in September 2024, the Australian Institute of Health and Welfare projected that the number of people with dementia in Australia will more than double, from about 411,100 in 2023 to 849,300 by 2058, impacting about 315,500 men and 533,800 women. Consequently, the escalating incidence of mental health disorders is driving the growth of the antipsychotic drug market.

The antipsychotic drugs market covered in this report is segmented –

1) By Therapeutic Class: First Generation, Second Generation, Third Generation

2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases

3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines

2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone

3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine

What Notable Trends Are Shaping The Direction Of The Antipsychotic Drugs Market?

Leading businesses in the antipsychotic drug market are endeavouring to create enhanced medical solutions, such as subcutaneous atypical antipsychotic injections. These innovative drugs are designed to provide superior patient adherence and increased efficiency than conventional oral drugs. Administered beneath the skin, these powerful injectable psychiatric medications are designed to manage mental disorders better, maintain steady blood levels, and amplify symptom control. For instance, in April 2023, Teva Pharmaceutical Industries Ltd., hailing from Israel, and France’s MedinCell SA, a biological product, and pharmaceutical manufacturer, initiated the launch of the U.S. FDA-approved UZEDY. It’s created as a risperidone extended-release injectable formulation, intended as a subcutaneous injection applicable for long periods, offering one to two months flexible dosing intervals. UZEDY, powered by MedinCell’s proprietary SteadyTeq technology, guarantees a balanced medication release, achieving therapeutic levels within just 6–24 hours of administration. Clinical trials highlighted UZEDY’s effectiveness, displaying an up to 80% reduction in schizophrenia relapse risk compared to placebo. It is designed to rectify adherence complications often linked with oral antipsychotics, typically causing relapses.

Who Are The Key Contributors To Growth In The Antipsychotic Drugs Market?

Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Which Region Is Projected To Lead The Antipsychotic Drugs Market By 2025?

North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18780&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model